Carel le Roux, PhD, discusses the full results from SYNCHRONIZE-1, a trial investigating Boehringer Ingelheim’s dual GLP-1/glucagon agonist.
Carel le Roux, PhD, MSC
Advertisement
Carel le Roux, PhD, MSC, is a director of the Metabolic Medicine Group at the University College of Dublin School of Medicine.
Articles by Carel le Roux, PhD, MSC
Carel le Roux, PhD, MSC, discusses the investigative dual GLP-1/glucagon agonist’s weight loss efficacy in patients with obesity and overweight without T2D.
Advertisement
Latest Updated Articles
Advertisement
Advertisement